missing translation for 'onlineSavingsMsg'
Learn More
Learn More
MP Biomedicals™ FastPrep-24™ 5G Bead Beating Grinder and Lysis System
Sfoglia Tutto MP Biomedicals ProdottiDescrizione
- Product Overview: The FastPrep-24 5G is a versatile sample disruption instrument designed to quickly and efficiently homogenize, grind, or lyse biological samples. A completely self-contained system, the FastPrep-24 5G eliminates the risk of cross-contamination and time-consuming clean-up associated with manual lysis methods. Samples are added to individual lysing matrix tubes and placed into sample holder adapters within the instrument. The unique, optimized motion of the FastPrep-24 5G shakes the samples in a tridimensional motion resulting in the collision of the sample material with the lysing matrix particles.
- Intuitive software makes programming the FastPrep-24 5G fast and simple. The programmable touchscreen display allows for the use of pre-determined or custom homogenization speeds and duration times with a finger touch. Increased power features result in faster processing times and complete lysis of even the toughest samples.
- Service Plan: One-year warranty is included with purchase.
- Sample Volume: ∼200 μL to 50 mL; up to ∼25 g
Specifica
Specifica
| Tipo di campione | Plant, Tissue, Bacteria, Fungi, Soil, Feces, Insect |
| Display | Touch screen |
| Run Time | 1 to 120 sec. |
| Volume del campione | 200 μL to 50 mL, up to 25 g |
| Altezza (sistema metrico) | 490 mm |
| Peso (sistema imperiale) | 52 lb. |
| Peso (sistema metrico) | 23.6 kg |
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use.
Titolo del prodotto
Facendo clic su Invia, l'utente riconosce che potrebbe essere contattato da Fisher Scientific in merito al feedback fornito in questo modulo. Non condivideremo le vostre informazioni per altri scopi. Tutte le informazioni di contatto fornite saranno conservate in conformità con la nostra Politica sulla privacy. Informativa sulla privacy.
Individuate un'opportunità di miglioramento?
